February 20, 2017 – Finasteride,  is a medication used for the treatment of benign prostatic hyperplasia (on the market as Proscar (5mg) since 1992 for this indication) and male pattern hair loss (on the market as Propecia (1mg) since 1997 for this indication). Finasteride is a type II and type III 5α-reductase inhibitor, 5α-reductase …

The Post Finasteride Syndrome (PFS): Are young men left alone until up to suicide? Read more »

February 16, 2017 – The American Food & Drug Administration (FDA) just approved Brodalumab (Siliq) to treat adults with moderate-to-severe plaque psoriasis. Brodalumab (Siliq) is administered as an injection. Brodalumab (Siliq) is intended for patients who are candidates for systemic therapy (treatment …

Brodalumab (Siliq) with a fatal touch: New psoriasis drug approved Read more »